NABsys, Inc.-Affiliated Scientists Receive Two of the Eight 'Revolutionary Genome Sequencing Technologies – The $1,000 Genome' Awards from the National Human Genome Research Institute
Published: Aug 02, 2007
PROVIDENCE, R.I.--(BUSINESS WIRE)--NABsys, Inc. announced today that two NABsys-affiliated scientists, Dr. John Oliver, Vice President of Research and Development, and Dr. Xinsheng Sean Ling, NABsys founder and principal academic collaborator and Associate Professor of Physics at Brown University, have received two of the eight “Revolutionary Genome Sequencing Technologies – The $1,000 Genome” awards from the National Human Genome Research Institute (NHGRI), an institute of the National Institutes of Health (NIH). NABsys was the only company, rather than academic lab, to receive an award. The funds will support the development of NABsys’ proprietary Hybridization-Assisted Nanopore Sequencing (HANS) platform which the company expects will decrease the cost of whole-genome sequencing to well under $1,000 per person/patient, allowing for the widespread implementation of personalized medicine.